Allscripts is extending its partnership with Microsoft to use the tech giant's cloud technology to enhance its electronic health record (EHR) software. The new five-year strategic partnership will ...

CHICAGO, April 23, 2013 /PRNewswire/ -- Allscripts took another key step in delivering an Open, Connected Community of Health™ with the release of Allscripts Care Director™. The new solution ...

Allscripts announced July 30 that Strata Decision Technology will acquire its healthcare decision analytics and budgeting business Epsi for $365 million. The transaction is expected to close later ...

LOWELL, Mass.--(BUSINESS WIRE)-- DiagnosisOne, the clinical decision support and analytics company, today announced a strategic agreement with Allscripts, the leading global provider of Electronic ...

Allscripts announced on Thursday after stock markets closed that it is buying rival McKesson’s health IT unit. For $185 million in cash, Allscripts gains the product portfolio McKesson calls ...

Allscripts Healthcare Solutions' payer and life sciences division, Veradigm, has inked a contract with the Social Security Administration, the U.S. agency that administers Social Security retirement ...

The initial release, for inclusion on any electronic health record within the clinical workflow, will include real-time key performance indicators to help inform and guide immediate clinical ...

Allscripts announced on Wednesday that it had entered into an agreement with Toronto-based Constellation Software's N. Harris Computer Corporation to acquire the net assets of the electronic health ...

CHICAGO, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ:MDRX), a global leader in healthcare technology, today announced a definitive agreement to acquire Practice Fusion, for $100 million in ...

CHICAGO & REDMOND, Wash.--(BUSINESS WIRE)--Today Allscripts (MDRX: NASDAQ) and Microsoft Corp. announced the extension of their long-standing strategic alliance to enable the expanded development and ...

Allscripts Healthcare Solutions on Thursday posted a nearly 7% rise in year-over-year second-quarter revenue as it continues to refocus its business on its payer and life sciences division, Veradigm.